학술논문
718O - PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
Document Type
Abstract
Author
Source
In Annals of Oncology 1 October 2016 27 Supplement 6:vi243-vi243
Subject
Language
ISSN
0923-7534